| Typicality: | 0.693 |
| Saliency: | 0.828 |
| in 1996 | 53 | temporal |
| recently | 48 | temporal |
| in 2012 | 32 | temporal |
| drug → be approved by → the fda | 1173 |
| drug → be approved by → fda | 148 |
| drug → be → fda-approved | 146 |
| drug → be approved by → the us fda | 25 |
| drug → be approved by → the u.s. fda | 6 |
| drug → be approved by → company | 4 |
| negative | neutral | positive |
| 0.145 | 0.575 | 0.280 |
| Raw frequency | 1502 |
| Normalized frequency | 0.828 |
| Modifier score | 0.775 |
| Perplexity | 22.529 |